Satellos Bioscience Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MSLE | SLDB | ACTI.ST | DSGN | XINT.ST | VIVOBIOT.BO | |
|---|---|---|---|---|---|---|
| Market cap | 137.27M | 699.11M | 102.54M | 665.24M | 124.45M | 328.87M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.5 | -3.8 | — | -6.6 | — | — |
| Price/book | 2.3 | 2.9 | 2.8 | 3.0 | -4.5 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +8.33% | +54.69% | −34.67% | +57.86% | −60.80% | −58.81% |
| Today | +1.57% | +3.82% | +5.71% | +2.80% | +0.35% | +6.77% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MSLE news ›Satellogic (SATL) Expected to Announce Quarterly Earnings on Tuesday
Posted by Sarita Garza on Nov 3rd, 2026 Read Our Latest Stock Report on SATL Founded in 2010 by Emiliano Kargieman, Satellogic is headquartered in Montevideo, Uruguay, and serves customers in multiple international markets. B. Riley…
Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin Compounds
Lakewood-Amedex Biotherapeutics Inc. announced the expansion of the Company's patent portfolio with the issuance of a new patent in Australia protecting Bisphosphocin compounds that are being explored... announced the expansion of the…
Satellos Bioscience Inc. (NASDAQ:MSLE) Stock Has Consensus Target Price of $20.60
Posted by Defense World Staff on Oct 26th, 2026 View Our Latest Report on Satellos Bioscience Satellos Bioscience (NASDAQ:MSLE – Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.56)…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net1
- marketscreener.com1
- theglobeandmail.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.